CoChat

Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials

Caissutti, Claudia, Saccone, Gabriele, Khalifeh, Adeeb, Mackeen, A. Dhanya, Lott, Melisa, Berghella, Vincenzo · 2019 · The Journal of Maternal-Fetal & Neonatal Medicine

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Abstract

Introduction: There is inconclusive evidence to support any specific criteria for starting pharmacologic therapy after diet in women with gestational diabetes mellitus (GDM). We aimed to analyze the most used criteria for starting pharmacologic treatment for patients with GDM.Material and methods: Electronic databases were searched from their inception to September 2017. We included all the randomized controlled trials (RCTs) of GDM managed initially by diet and exercise reporting criteria for starting pharmacologic therapy. RCTs in women with pregestational diabetes were excluded. Data regarding glucose values used for starting pharmacologic therapy were extracted and carefully reviewed.Results: We included 15 RCTs (4307 women) in the meta-analysis. For fasting glucose target, 8/14 (57%) used a value lower or equal to 90 mg/dL and the remainder used values <99 mg/dL. Of the 10 RCTs targeting 2-h postprandial values, the majority (9/10, 90%) used 120 mg/dL. The majority of RCTs (13/15, 87%) recommended pharmacologic therapy if either 1 or 2 values per 1- or 2-week period were higher than the target values: 7/13 (54%) used 1 value and 6/13 (46%) used 2 values higher than target values. One RCT (7%) used >50% of the values higher than the target values and another one (7%) used >30%.Conclusion: The majority of RCTs (87%) used very tight criteria of either 1 or 2 values over the target values in the 1 or 2-week period for starting pharmacologic treatment for patients with GDM; more than 50% used 2 values.Key MessagePharmacologic therapy should be considered in women with gestational diabetes when, despite an adequate diet and exercise, 1 or 2 blood glucose values are over the target values of 90mg/dL fasting or 120mg/dL 2-hour postprandial over 1 or 2 weeks.

Overview

Integrity signals

Registry

Crossref · 10.1080/14767058.2018.1449203

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Research works printed but not linked: 10

  1. Mesdaghinia E, 2013, Int J Prev Med, 4, 327
  2. Cypryk K, 2004, Med Sci Monit, 10, 29
  3. Hassan JA, 2012, Pak J Med Sci, 28, 384
  4. Mirzamoradi M, 2015, Acta Med Iran, 53, 97
  5. Refuerzo JS, 2015, Am J Perinatol, 30, 163
  6. Thompson DJ, 1990, Obstet Gynecol, 75, 960
  7. Waheed S, 2013, J Coll Physicians Surg Pak, 23, 866
  8. 2015, International Diabetes Federation, Atlas I
  9. Saccone G, J Matern Fetal Neonatal Med, 1
  10. Brown J, 2017, Cochrane Database Syst Rev, 11, CD012037

Cited by

See all 13

Metadata

Authors
Caissutti, C., Saccone, G., Khalifeh, A., Mackeen, A. D., Lott, M., & Berghella, V.
Affiliations
  • University of Udine (IT)
  • University of Naples Federico II (IT)
  • Thomas Jefferson University (US)
  • Geisinger Medical Center (US)
Corresponding author
Berghella, Vincenzo
Venue
The Journal of Maternal-Fetal & Neonatal Medicine
Published
2018-03-20
Volume
32
Issue
17
Pages
2905-2914
ISSN
  • 1476-4954 (ISSN-L)
  • 1476-7058
OpenAlex
W2792561718
Cited by
13
References
69
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1
FWCI
0.24
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, treatment thresholds, 2-hour postprandial glucose, glycemic control, randomized controlled trials
MeSH terms
Blood Glucose, Female, Glucose Tolerance Test, Humans, Pregnancy, Randomized Controlled Trials as Topic, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials. https://app.cochat.ai/papers/10.1080/14767058.2018.1449203
The paper
Caissutti, C., Saccone, G., Khalifeh, A., Mackeen, A. D., Lott, M., & Berghella, V. (2019). Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.1080/14767058.2018.1449203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.